AmplifyBio’s non-viral precision genome editing methods offer several advantages over viral insertion, primarily in terms of safety, precision, efficiency, and flexibility.
As an expert contract research organization (CRO), AmplifyBio leverages decades of experience to create modern commercial drug development solutions. From CRO and preclinical CRO needs to cell and gene therapy and advanced therapy testing, our accredited team designs innovative paths to produce globally recognized studies, services, and more.
